{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:39:43Z","timestamp":1792179583429,"version":"4.4.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:00:00Z","timestamp":1128643200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Compared with their ovarian counterparts, serous borderline tumors of the fallopian tube are uncommon, with limited experience about their clinical behaviour. We present a case of serous borderline tumor of the fallopian tube with unusual presentation and summarise all the published cases to date.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A case of serous borderline tumor of the fallopian tube in a 34-year old patient is presented, incidentally found during routine gynecologic examination. At laparoscopy the tumor was unusualy presented as hematosalpinx and was treated by salpingectomy. Cell-cycle analysis of the tumor tissue revealed a diploid DNA content and a low S-phase fraction. There was no evidence of the disease during the follow-up period of 4.6 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The current case and review of the literature suggest salpingectomy as the optimal treatment for patients with serous borderline tumor of the fallopian tube.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2407-5-129","type":"journal-article","created":{"date-parts":[[2005,10,8]],"date-time":"2005-10-08T06:13:58Z","timestamp":1128752038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Serous borderline tumor of the fallopian tube presented as hematosalpinx: a case report"],"prefix":"10.1186","volume":"5","author":[{"given":"Maja","family":"Krasevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Smiljan-Severinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,10,7]]},"reference":[{"key":"317_CR1","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jso.2930330314","volume":"33","author":"V Gatto","year":"1986","unstructured":"Gatto V, Selim MA, Lankerani M: Primary carcinoma of the fallopian tube in an adolescent. J Surg Oncol. 1986, 33: 212-214.","journal-title":"J Surg Oncol"},{"key":"317_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00004347-199707000-00001","volume":"16","author":"I Alvarado-Cabrero","year":"1997","unstructured":"Alvarado-Cabrero I, Navani SS, Young RH, Scully RE: Tumors of the fimbriated end of the fallopian tube: a clinicopathologic analysis of 20 cases, including nine carcinomas. Int J Gynecol Pathol. 1997, 16: 189-196.","journal-title":"Int J Gynecol Pathol"},{"key":"317_CR3","first-page":"256","volume":"7","author":"SV Casasola","year":"1989","unstructured":"Casasola SV, Mindan JP: Cystadenofibroma of the fallopian tube. Appl Pathol. 1989, 7: 256-259.","journal-title":"Appl Pathol"},{"key":"317_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/00004347-200010000-00019","volume":"19","author":"E Kayaalp","year":"2000","unstructured":"Kayaalp E, Heller DS, Majmudar B: Serous tumor of low malignant potential of the fallopian tube. Int J Gynecol Pathol. 2000, 19: 398-400. 10.1097\/00004347-200010000-00019.","journal-title":"Int J Gynecol Pathol"},{"key":"317_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/00000478-199601000-00003","volume":"20","author":"W Zheng","year":"1996","unstructured":"Zheng W, Wolf S, Kramer EE, Cox KA, Hoda SA: Borderline papillary serous tumor of the fallopian tube. Am J Surg Pathol. 1996, 20: 30-35. 10.1097\/00000478-199601000-00003.","journal-title":"Am J Surg Pathol"},{"key":"317_CR6","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7863\/jum.2004.23.6.869","volume":"23","author":"N Haratz-Rubinstein","year":"2004","unstructured":"Haratz-Rubinstein N, Fromberg E, Lederman S: Sonographic diagnosis of serous tumor of low malignant potential of the fallopian tube. J Ultrasound Med. 2004, 23: 869-872.","journal-title":"J Ultrasound Med"},{"key":"317_CR7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1053\/hp.2000.8048","volume":"31","author":"JD Seidman","year":"2000","unstructured":"Seidman JD, Kurman RJ: Ovarian serous borderline tumors: a critical rewiev of the literature with emphasis on prognostic indicarors. Hum Pathol. 2000, 31: 539-557. 10.1053\/hp.2000.8048.","journal-title":"Hum Pathol"},{"key":"317_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1525-1438.1993.03060349.x","volume":"3","author":"J Kaern","year":"1993","unstructured":"Kaern J, Trope CG, Kristensen GB, Abeler VM, Pettersen EO: DNA ploidy; the most important prognostic factor in patients with borderline tumors of the ovary. Int J Gynecol Cancer. 1993, 3: 349-358. 10.1046\/j.1525-1438.1993.03060349.x.","journal-title":"Int J Gynecol Cancer"},{"key":"317_CR9","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1494::AID-CNCR11>3.0.CO;2-V","volume":"77","author":"D Demirel","year":"1996","unstructured":"Demirel D, Laucirica R, Fishman A, et al: Ovarian tumors of low malignant potential: correlation of DNA index and S-phase fraction with histopathologic grade and clinical outcome. Cancer. 1996, 77: 1494-1500. 10.1002\/(SICI)1097-0142(19960415)77:8<1494::AID-CNCR11>3.0.CO;2-V.","journal-title":"Cancer"},{"key":"317_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00004347-200301000-00008","volume":"22","author":"CB Gilks","year":"2003","unstructured":"Gilks CB, Alkushi A, Yue JJS, Lanvin D, Ehlen TG, Miller DM: Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol. 2003, 22: 29-36. 10.1097\/00004347-200301000-00008.","journal-title":"Int J Gynecol Pathol"},{"key":"317_CR11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2559.1988.tb02028.x","volume":"13","author":"JH McCarthy","year":"1988","unstructured":"McCarthy JH, Aga R: A fallopian tube lesion of borderline malignancy associated with pseudo-myxoma peritonei. Histopathology. 1988, 13: 223-225.","journal-title":"Histopathology"},{"key":"317_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1055\/s-2008-1026305","volume":"50","author":"W Friedmann","year":"1990","unstructured":"Friedmann W, Minguillon C, Wessel J, Lichetenegger W, Pickel H: (Pseudomyxoma peritonei caused by proliferating mucinous adenoma of the mucosa of the fimbriae). Geburtshilfe Frauenheilkd. 1990, 50: 579-580.","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"317_CR13","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/00000478-199412000-00003","volume":"18","author":"JD Seidman","year":"1994","unstructured":"Seidman JD: Mucinous lesions of the fallopian tube. Am J Surg Pathol. 1994, 18: 1205-1212.","journal-title":"Am J Surg Pathol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-5-129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-5-129\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-5-129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-5-129.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:03:49Z","timestamp":1630447429000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-5-129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,7]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-5-129","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,7]]},"assertion":[{"value":"14 June 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"129"}}